Panbela Therapeutics (PBLA) Financials

$0.00

$-0.32 (-99.97%)

As on 07-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	-1.64	--	--	--
Cost of Revenue	29.04	25.65	35.73	10.01	5.75	4.32
Gross Profit	-29.04	-25.65	-35.73	-10.01	-5.75	-4.32
Operating Expenses	29.04	25.65	34.09	10.01	5.75	4.32
Operating Profit (EBIT)	-36.20	-51.29	-34.09	-10.01	-5.75	-4.32
Other Income	--	--	--	--	--	--
Profit before Tax	-28.06	-25.45	-35.05	-10.62	-5.06	-6.62
Provision for Tax	-0.10	-0.19	-0.12	-0.49	-0.30	-0.42
Profit after Tax (Net Income)	-27.91	-25.26	-34.93	-10.14	-4.77	-6.20
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-34.93	-10.14	-4.77	-6.20

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-18.17	-4.71	-8.05	10.21	8.45	1.39
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.19	4.19	5.19	0.64	0.55	0.71
Current Liabilities	20.14	12.32	7.83	2.66	1.37	1.76
Total Liabilities	25.31	11.80	4.98	12.87	9.81	3.14

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	--	8.74	3.20	0.59	0.06	0.05
Current Assets	5.17	3.06	1.78	12.28	9.76	3.09
Total Assets	25.31	11.80	4.98	12.87	9.81	3.14
Total Debt*	6.39	5.19	6.84	--	--	0.12
Net Current Assets	-14.97	-9.26	-6.06	9.62	8.39	1.33

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-25.25	-15.28	-6.70	-3.85	-2.74
Cash Flow from Investing Activities	--	0.40	-0.66	-0.54	-0.54	-0.54
Cash from Financing Activities	--	26.14	5.35	10.10	10.44	3.78
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-7.30	-8.08	-24,952.14	-16,891.67	-596.00	-1,127.27
Cash EPS ($)	--	-8.08	-24,952.14	-16,891.67	-596.00	-1,127.27
Adjusted Book Value ($)	--	--	--	17,020.00	1,056.00	251.82
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-8.08	-10,911.43	-11,173.33	-481.75	-498.00
Free Cash Flow per Share ($)	--	-8.08	-11,382.86	-11,173.33	-481.75	-498.00

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	7,007.77	-775.69	-108.63	-95.85	-585.18
ROE (%)	--	396.00	-3,230.05	-108.63	-96.98	-750.15
ROA (%)	-124.42	-301.11	-391.41	-89.35	-73.60	-245.93
EBIT Margin (%)	--	--	2,122.16	--	--	--
Net Margin (%)	--	--	2,132.66	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	1.00	--	--	--	--
EBIT Growth (%)	-48.18	25.88	-227.29	-110.48	-14.14	-150.64
Net Profit Growth (%)	-18.69	27.68	-244.68	-112.56	23.10	-5.00
EPS Growth (%)	99.82	1.00	-0.48	-27.34	0.47	0.20
Book Value Growth (%)	78.04	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.11	0.00	0.00	-0.01	0.00
Price / Book Value	3.22	-0.61	0.00	0.00	0.00	0.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.22	-0.21	-0.16	1.12	1.82	0.52
Close Price ($)	0.36	18.30	1,759.20	41,522.40	85,440.00	100,800.00
High Price ($)	38.00	4,509.60	57,600.00	211,200.00	240,000.00	168,000.00
Low Price ($)	0.30	9.00	1,250.40	38,400.00	56,882.40	48,000.00
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	-0.18	-1.10	-0.85	--	--	0.08
Short term debt to equity ratio	-0.18	-0.21	-0.20	--	--	0.08
Current Ratio	0.26	0.25	0.23	4.62	7.15	1.76
Quick Ratio	0.26	--	--	--	--	--
Interest Coverage	-43.12	-81.28	-120.70	-965.55	-296.82	-2.02

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	-2.99	--	--	--
Asset Turnover	--	--	-0.18	--	--	--
Receivable days	--	--	-41.25	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	91.17	17.91	21.78	36.53	70.19
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.